seri
heterocycl
compound
design
potenti
nonnucleosid
hiv
revers
transcriptas
inhibitor
although
compound
ultim
prove
inact
hiv
cours
synthesi
new
highli
facil
method
realiz
nphenylacetamid
develop
notabl
new
rout
avoid
intract
workup
byproduct
previous
report
procedur
associ
therebi
make
approach
highli
attract
adapt
heterocycl
elsevi
ltd
right
reserv
part
ongo
effort
synthes
aryl
heteroaromat
nonnucleosid
hiv
revers
transcriptas
inhibitor
nnrti
sought
construct
new
seri
phenylacetamid
use
alkyl
variou
uracil
amid
unit
one
import
wide
occur
function
group
present
mani
natur
product
key
featur
mani
import
drug
among
notabl
exampl
amidecontain
compound
found
conjunct
nheterocycl
exhibit
divers
mark
pharmacolog
activ
particular
nnrti
dihydrofol
reductas
dhfr
inhibitor
histon
deacetylas
hdac
inhibitor
stand
surpris
therefor
numer
paper
amid
bond
format
describ
despit
plethora
avail
rout
plagu
problem
particular
low
yield
difficult
workup
result
new
facil
rout
sought
preliminari
search
literatur
reveal
sever
known
method
format
commonli
use
methodolog
involv
condens
chloroacetyl
chlorid
variou
anilin
aprot
solvent
eg
ether
dioxan
chloroform
dichloromethan
ethyl
acet
dmf
presenc
anhydr
k
co
triethylamin
pyridin
base
anoth
variant
util
methylethylketon
caco
refer
describ
condens
promot
triethylamin
acet
acid
exampl
anilin
acyl
acet
buffer
aqueou
k
co
also
known
anoth
approach
propos
synthesi
basefre
condit
latter
case
reaction
take
place
nonpolar
solvent
mix
solvent
system
although
mani
option
avail
import
note
method
suffer
numer
side
reaction
aris
either
nquatern
organ
base
hydrolysi
lead
low
yield
tediou
workup
procedur
howev
shown
amid
bond
format
could
achiev
cleavag
siliconnitrogen
bond
tmsprotect
alkylamin
anilin
acid
halid
absenc
base
render
silyl
method
attract
synthesi
serv
bypass
problem
side
reaction
quatern
hydrolysi
common
aforement
rout
surprisingli
inform
literatur
prepar
util
silyl
methodolog
result
employ
approach
synthes
seri
shown
scheme
use
synthesi
desir
nnrti
shown
scheme
start
anilin
convert
ntrimethylsilyl
deriv
reflux
excess
hmd
form
nsilyl
intermedi
follow
treatment
chloroacetyl
chlorid
anhydr
produc
target
see
front
matter
seri
heterocycl
compound
design
potenti
nonnucleosid
hiv
revers
transcriptas
inhibitor
although
compound
ultim
prove
inact
hiv
cours
synthesi
new
highli
facil
method
realiz
nphenylacetamid
develop
notabl
new
rout
avoid
intract
workup
byproduct
previous
report
procedur
associ
therebi
make
approach
highli
attract
adapt
heterocycl
elsevi
ltd
right
reserv
part
ongo
effort
synthes
aryl
heteroaromat
nonnucleosid
hiv
revers
transcriptas
inhibitor
nnrti
sought
construct
new
seri
phenylacetamid
use
alkyl
variou
uracil
amid
unit
one
import
wide
occur
function
group
present
mani
natur
product
key
featur
mani
import
drug
among
notabl
exampl
amidecontain
compound
found
conjunct
nheterocycl
exhibit
divers
mark
pharmacolog
activ
particular
nnrti
dihydrofol
reductas
dhfr
inhibitor
histon
deacetylas
hdac
inhibitor
stand
surpris
therefor
numer
paper
amid
bond
format
describ
despit
plethora
avail
rout
plagu
problem
particular
low
yield
difficult
workup
result
new
facil
rout
sought
preliminari
search
literatur
reveal
sever
known
method
format
commonli
use
methodolog
involv
condens
chloroacetyl
chlorid
variou
anilin
aprot
solvent
eg
ether
dioxan
chloroform
dichloromethan
ethyl
acet
dmf
presenc
anhydr
k
co
triethylamin
pyridin
base
anoth
variant
util
methylethylketon
caco
refer
describ
condens
promot
triethylamin
acet
acid
exampl
anilin
acyl
acet
buffer
aqueou
k
co
also
known
anoth
approach
propos
synthesi
basefre
condit
latter
case
reaction
take
place
nonpolar
solvent
mix
solvent
system
although
mani
option
avail
import
note
method
suffer
numer
side
reaction
aris
either
nquatern
organ
base
hydrolysi
lead
low
yield
tediou
workup
procedur
howev
shown
amid
bond
format
could
achiev
cleavag
siliconnitrogen
bond
tmsprotect
alkylamin
anilin
acid
halid
absenc
base
render
silyl
method
attract
synthesi
serv
bypass
problem
side
reaction
quatern
hydrolysi
common
aforement
rout
surprisingli
inform
literatur
prepar
util
silyl
methodolog
result
employ
approach
synthes
seri
shown
scheme
use
synthesi
desir
nnrti
shown
scheme
start
anilin
convert
ntrimethylsilyl
deriv
reflux
excess
hmd
form
nsilyl
intermedi
follow
treatment
chloroacetyl
chlorid
anhydr
produc
target
tabl
notabl
occur
without
tarlik
byproduct
typic
observ
reaction
target
nphenylacetamid
obtain
excel
almost
quantit
yield
see
tabl
alkyl
appropri
presenc
molar
excess
k
co
dmf
shown
scheme
analog
fashion
nphenylacetamid
synthes
start
benzhydryl
uracil
respect
note
compound
obtain
without
suffer
intract
workup
side
product
typic
procedur
associ
therebi
make
approach
highli
attract
adapt
heterocycl
compound
compound
evalu
inhibitor
larg
set
dna
rna
virus
disappointingli
none
prove
activ
strain
test
includ
hcmv
vzv
vaccinia
viru
viru
sindbi
viru
vesicular
stomat
viru
respiratori
syncyti
viru
coxsacki
viru
felin
corona
viru
summari
target
nnrti
synthes
prove
inact
facil
highyield
rout
nphenylacetamid
develop
prove
use
mani
synthet
applic
employ
heterocycl
amid
